by Dewetting: From Physics to the Biology of Intoxicated Cells
Pathogenic micro organism colonize or disseminate into cells and tissues by inducing large-scale remodeling of host membranes. The bodily phenomena underpinning these big membrane extension and deformation are poorly understood. Invasive strategies of pathogens have been simply recently enriched by the define of a spectacular mode of opening of huge transendothelial cell macroaperture (TEM) tunnels correlated to the dissemination of EDIN-producing strains of Staphylococcus aureus by means of a hematogenous route or to the induction of gelatinous edema triggered by the edema toxin from Bacillus anthracis.
Remarkably, these extraordinarily dynamic tunnels shut shortly after they attain a maximal measurement. Opening and closure of TEMs in cells lasts for hours with out inducing endothelial cell demise. Multidisciplinary analysis have started to produce a broader perspective of every the molecular determinants controlling cytoskeleton group at newly curved membranes generated by the opening of TEMs and the bodily processes controlling the dynamics of these tunnels.
Proper right here we speak in regards to the analogy between the opening of TEM tunnels and the bodily concepts of dewetting, stemming from a parallel between membrane stress and ground stress. This analogy provides a broad framework to analysis biophysical constraints in cell membrane dynamics and their diversion by positive invasive microbial brokers
Present advances in myeloid-derived suppressor cell biology
In latest occasions, discovering out the place of myeloid-derived suppressor cells (MDSCs) in numerous pathological inflammatory conditions has become a very energetic evaluation area. Although the place of MDSCs in most cancers is relatively successfully established, their place in non-cancerous pathological conditions stays in its infancy resulting in rather a lot confusion. Our targets on this overview are to cope with some present advances in MDSC evaluation in order to lower such confusion and to produce an notion into their function inside the context of various illnesses.
The following issues is perhaps significantly centered upon:
(1) definition and characterization of MDSCs;
(2) whether or not or not all MDSC populations embrace immature cells;
(3) technical factors in MDSC isolation, estimation and characterization;
(4) the origin of MDSCs and their anatomical distribution in effectively being and sickness;
(5) mediators of MDSC development and accumulation;
(6) parts that determine the expansion of 1 MDSC inhabitants over the other;
(7) the Yin and Yang roles of MDSCs. Moreover, the capabilities of MDSCs is perhaps addressed all by the textual content material.
Ob Blocking Peptide |
|||
| DF8583-BP | Affbiotech | 1mg | EUR 234 |
ST Blocking Peptide |
|||
| DF8616-BP | Affbiotech | 1mg | EUR 234 |
AR Blocking Peptide |
|||
| DF6783-BP | Affbiotech | 1mg | EUR 234 |
MB Blocking Peptide |
|||
| DF7358-BP | Affbiotech | 1mg | EUR 234 |
FH Blocking Peptide |
|||
| DF7460-BP | Affbiotech | 1mg | EUR 234 |
CP Blocking Peptide |
|||
| DF9369-BP | Affbiotech | 1mg | EUR 234 |
C7 Blocking Peptide |
|||
| DF9410-BP | Affbiotech | 1mg | EUR 234 |
C5 Blocking Peptide |
|||
| DF7719-BP | Affbiotech | 1mg | EUR 234 |
GC Blocking Peptide |
|||
| DF7840-BP | Affbiotech | 1mg | EUR 234 |
TG Blocking Peptide |
|||
| DF7885-BP | Affbiotech | 1mg | EUR 234 |
T Blocking Peptide |
|||
| BF0015-BP | Affbiotech | 1mg | EUR 234 |
E7 Blocking Peptide |
|||
| BF0311-BP | Affbiotech | 1mg | EUR 234 |
AR Blocking Peptide |
|||
| BF0418-BP | Affbiotech | 1mg | EUR 234 |
PR Blocking Peptide |
|||
| BF0581-BP | Affbiotech | 1mg | EUR 234 |
RB Blocking Peptide |
|||
| BF0614-BP | Affbiotech | 1mg | EUR 234 |
ER Blocking Peptide |
|||
| BF0674-BP | Affbiotech | 1mg | EUR 234 |
OR Blocking Peptide |
|||
| DF10250-BP | Affbiotech | 1mg | EUR 234 |
GK Blocking Peptide |
|||
| DF3151-BP | Affbiotech | 1mg | EUR 234 |
C6 Blocking Peptide |
|||
| DF3963-BP | Affbiotech | 1mg | EUR 234 |
C9 Blocking Peptide |
|||
| DF3964-BP | Affbiotech | 1mg | EUR 234 |
MB Blocking Peptide |
|||
| DF4194-BP | Affbiotech | 1mg | EUR 234 |
NT Blocking Peptide |
|||
| DF4245-BP | Affbiotech | 1mg | EUR 234 |
PC Blocking Peptide |
|||
| DF4364-BP | Affbiotech | 1mg | EUR 234 |
F3 Blocking Peptide |
|||
| DF6400-BP | Affbiotech | 1mg | EUR 234 |
HP Blocking Peptide |
|||
| DF6467-BP | Affbiotech | 1mg | EUR 234 |
F9 Blocking Peptide |
|||
| DF6474-BP | Affbiotech | 1mg | EUR 234 |
GW Blocking Peptide |
|||
| 20-abx162574 | Abbexa |
|
|
GK Blocking Peptide |
|||
| AF0829-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
| AF5004-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
| AF6066-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
| AF6067-BP | Affbiotech | 1mg | EUR 234 |
TK Blocking Peptide |
|||
| AF6068-BP | Affbiotech | 1mg | EUR 234 |
TK Blocking Peptide |
|||
| AF7678-BP | Affbiotech | 1mg | EUR 234 |
Rb Blocking Peptide |
|||
| AF7698-BP | Affbiotech | 1mg | EUR 234 |
IR Blocking Peptide |
|||
| AF6098-BP | Affbiotech | 1mg | EUR 234 |
IR Blocking Peptide |
|||
| AF6099-BP | Affbiotech | 1mg | EUR 234 |
Ub Blocking Peptide |
|||
| MBS8247910-1mg | MyBiosource | 1mg | EUR 190 |
Ub Blocking Peptide |
|||
| MBS8247910-5mg | MyBiosource | 5mg | EUR 345 |
Ub Blocking Peptide |
|||
| MBS8247910-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
Ub Blocking Peptide |
|||
| MBS823327-1mg | MyBiosource | 1mg | EUR 190 |
Ub Blocking Peptide |
|||
| MBS823327-5mg | MyBiosource | 5mg | EUR 345 |
Ub Blocking Peptide |
|||
| MBS823327-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
GW Blocking Peptide |
|||
| MBS8202921-1mg | MyBiosource | 1mg | EUR 190 |
GW Blocking Peptide |
|||
| MBS8202921-5mg | MyBiosource | 5mg | EUR 345 |
GW Blocking Peptide |
|||
| MBS8202921-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
FX Blocking Peptide |
|||
| MBS8212235-1mg | MyBiosource | 1mg | EUR 190 |
FX Blocking Peptide |
|||
| MBS8212235-5mg | MyBiosource | 5mg | EUR 345 |
FX Blocking Peptide |
|||
| MBS8212235-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
C5 Blocking Peptide |
|||
| MBS9627011-1mg | MyBiosource | 1mg | EUR 380 |
C5 Blocking Peptide |
|||
| MBS9627011-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
CP Blocking Peptide |
|||
| MBS9628390-1mg | MyBiosource | 1mg | EUR 380 |
CP Blocking Peptide |
|||
| MBS9628390-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C7 Blocking Peptide |
|||
| MBS9628431-1mg | MyBiosource | 1mg | EUR 380 |
C7 Blocking Peptide |
|||
| MBS9628431-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
OR Blocking Peptide |
|||
| MBS9620585-1mg | MyBiosource | 1mg | EUR 380 |
OR Blocking Peptide |
|||
| MBS9620585-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C3 Blocking Peptide |
|||
| MBS9621927-1mg | MyBiosource | 1mg | EUR 380 |
C3 Blocking Peptide |
|||
| MBS9621927-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C6 Blocking Peptide |
|||
| MBS9624136-1mg | MyBiosource | 1mg | EUR 380 |
C6 Blocking Peptide |
|||
| MBS9624136-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C9 Blocking Peptide |
|||
| MBS9624137-1mg | MyBiosource | 1mg | EUR 380 |
C9 Blocking Peptide |
|||
| MBS9624137-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
F3 Blocking Peptide |
|||
| MBS9625773-1mg | MyBiosource | 1mg | EUR 380 |
F3 Blocking Peptide |
|||
| MBS9625773-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
HP Blocking Peptide |
|||
| MBS9625839-1mg | MyBiosource | 1mg | EUR 380 |
HP Blocking Peptide |
|||
| MBS9625839-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9626155-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9626155-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9617301-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9617301-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
NT Blocking Peptide |
|||
| MBS9624416-1mg | MyBiosource | 1mg | EUR 380 |
NT Blocking Peptide |
|||
| MBS9624416-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
PC Blocking Peptide |
|||
| MBS9624535-1mg | MyBiosource | 1mg | EUR 380 |
PC Blocking Peptide |
|||
| MBS9624535-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9618029-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9618029-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9620081-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9620081-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
PR Blocking Peptide |
|||
| MBS9620193-1mg | MyBiosource | 1mg | EUR 380 |
PR Blocking Peptide |
|||
| MBS9620193-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
RB Blocking Peptide |
|||
| MBS9620221-1mg | MyBiosource | 1mg | EUR 380 |
RB Blocking Peptide |
|||
| MBS9620221-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
ER Blocking Peptide |
|||
| MBS9620262-1mg | MyBiosource | 1mg | EUR 380 |
ER Blocking Peptide |
|||
| MBS9620262-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
T Blocking Peptide |
|||
| MBS9619752-1mg | MyBiosource | 1mg | EUR 380 |
T Blocking Peptide |
|||
| MBS9619752-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
E7 Blocking Peptide |
|||
| MBS9619999-1mg | MyBiosource | 1mg | EUR 380 |
E7 Blocking Peptide |
|||
| MBS9619999-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9620031-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9620031-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
FH Blocking Peptide |
|||
| MBS9626808-1mg | MyBiosource | 1mg | EUR 380 |
FH Blocking Peptide |
|||
| MBS9626808-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
V5 Blocking Peptide |
|||
| MBS9230730-INQUIRE | MyBiosource | INQUIRE | Ask for price |
GW Blocking Peptide |
|||
| MBS8309588-1mg | MyBiosource | 1mg | EUR 190 |
GW Blocking Peptide |
|||
| MBS8309588-5mg | MyBiosource | 5mg | EUR 345 |
GW Blocking Peptide |
|||
| MBS8309588-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
Mouse Lipin-1 Control/blocking peptide control/blocking peptide #1 |
|||
| LPN11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Mouse Lipin-2 Control/blocking peptide control/blocking peptide #1 |
|||
| LPN21-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Mouse Lipin-3 Control/blocking peptide control/blocking peptide #1 |
|||
| LPN31-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
C-Peptide Blocking Peptide |
|||
| 3277BP-50 | Biovision | each | EUR 183.6 |
PEPT1 Blocking Peptide |
|||
| 20-abx063272 | Abbexa |
|
|
PEPT1 Blocking Peptide |
|||
| MBS822938-1mg | MyBiosource | 1mg | EUR 190 |
PEPT1 Blocking Peptide |
|||
| MBS822938-5mg | MyBiosource | 5mg | EUR 345 |
PEPT1 Blocking Peptide |
|||
| MBS822938-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
MIF Blocking Peptide |
|||
| 5571BP-50 | Biovision | each | EUR 183.6 |
ECM Blocking Peptide |
|||
| 3843BP-50 | Biovision | each | EUR 183.6 |
Brk Blocking Peptide |
|||
| 3847BP-50 | Biovision | each | EUR 183.6 |
SCD Blocking Peptide |
|||
| 3875BP-50 | Biovision | each | EUR 183.6 |
Sp3 Blocking Peptide |
|||
| 3887BP-50 | Biovision | each | EUR 183.6 |
TP2 Blocking Peptide |
|||
| 3941BP-50 | Biovision | each | EUR 183.6 |
LPL Blocking Peptide |
|||
| 3947BP-50 | Biovision | each | EUR 183.6 |
PKG Blocking Peptide |
|||
| 3452BP-50 | Biovision | each | EUR 183.6 |
SGK Blocking Peptide |
|||
| 3459BP-50 | Biovision | each | EUR 183.6 |
Lck Blocking Peptide |
|||
| 3498BP-50 | Biovision | each | EUR 183.6 |
NSF Blocking Peptide |
|||
| 3541BP-50 | Biovision | each | EUR 183.6 |
PI9 Blocking Peptide |
|||
| 3544RBP-50 | Biovision | each | EUR 183.6 |
Tau Blocking Peptide |
|||
| 3549RBP-50 | Biovision | each | EUR 183.6 |
TTP Blocking Peptide |
|||
| 3551BP-50 | Biovision | each | EUR 183.6 |
LXR Blocking Peptide |
|||
| 3641BP-50 | Biovision | each | EUR 183.6 |
HDC Blocking Peptide |
|||
| 3691BP-50 | Biovision | each | EUR 183.6 |
JNK Blocking Peptide |
|||
| 3701BP-50 | Biovision | each | EUR 183.6 |
BIK Blocking Peptide |
|||
| 3703BP-50 | Biovision | each | EUR 183.6 |
BIF Blocking Peptide |
|||
| 3704BP-50 | Biovision | each | EUR 183.6 |
MRGPRX2 indicators its significance in cutaneous mast cell biology: Does MRGPRX2 be part of mast cells and atopic dermatitis?
The invention of MRGPRX2 marks a necessary change in MC biology, explaining non-IgE-mediated scientific phenomena relying on MCs. As receptor for quite a few remedy, MRGPRX2 is important to drug-induced hypersensitivity.
Nonetheless, not solely remedy, however moreover endogenous mediators like neuropeptides and host safety peptides activate MRGPRX2, suggesting its broad affect in cutaneous pathophysiology.
Proper right here, we give a brief overview of MRGPRX2 and its regulation by microenvironmental stimuli, which assist MCs and shall be altered in pores and pores and skin points, and briefly contact on the purposeful packages elicited by MRGPRX2 ligation. Analysis in Mrgprb2-deficient mice (the murine ortholog) help illuminate MRGPRX2’s function in effectively being and sickness.
Present advances on this model assist the long-suspected operational unit between MCs and nerves, with MRGPRX2 being an vital component. Based on the restricted proof for a big contribution of FcεRI/IgE-activated MCs to atopic dermatitis (AD), we develop the hypothesis that MRGPRX2 constitutes the missing hyperlink connecting MCs and AD, a minimum of in chosen endotypes.
Help comes from the multifold changes inside the MC-neuronal system of AD pores and pores and skin (e.g. bigger density of MCs and nearer connections between MCs and nerves, elevated PAR-2/Substance P).
We theorize that these deregulations suffice to impress AD, nonetheless exterior triggers, numerous which activating MRGPRX2 themselves (e.g. Staphylococcus aureus) extra feed into the loop. Itch, most likely probably the most burdensome hallmark of AD, is usually non-histaminergic nonetheless tryptase-dependent, and tryptase is preferentially launched upon MRGPRX2 activation. On account of MRGPRX2 is a very energetic evaluation space, a couple of of the current gaps are susceptible to be closed shortly.
Non-Muscle Myosin II in Axonal Cell Biology: From the Growth Cone to the Axon Preliminary Part
By binding to actin filaments, non-muscle myosin II (NMII) generates actomyosin networks that preserve distinctive contractile properties. Their dynamic nature is vital for neuronal biology along with the establishment of polarity, progress cone formation and motility, axon progress all through enchancment (and axon regeneration inside the grownup), radial and longitudinal axonal stress, and synapse formation and efficiency.
On this overview, we speak in regards to the current information on the spatial distribution and efficiency of the actomyosin cytoskeleton in quite a few axonal compartments.
We highlight a couple of of the plain contradictions and open questions inside the space, along with the place of NMII inside the regulation of axon progress and regeneration, the possibility that NMII structural affiliation alongside the axon shaft would possibly administration every radial and longitudinal contractility, and the mechanism and purposeful goal underlying NMII enrichment inside the axon preliminary part.
With the advances in reside cell imaging and super choice microscopy, it is anticipated that inside the near future the spatial distribution of NMII inside the axon, and the mechanisms by which it participates in axonal biology is perhaps extra untangled.
2-Bromo-4-aminobenzoic Acid |
|||
| TRC-B679450-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
2-Bromo-5-amino-4-picoline |
|||
| 20-abx180299 | Abbexa |
|
|
5-Bromo-2-aminopyrimidine |
|||
| B621550 | Toronto Research Chemicals | 10g | EUR 104 |
|
Description: 7752-82-1 |
|||
5-Bromo-2-aminopyrimidine |
|||
| MBS6114378-10g | MyBiosource | 10(g | EUR 505 |
5-Bromo-2-aminopyrimidine |
|||
| MBS6114378-5x10g | MyBiosource | 5x10g | EUR 2125 |
5-Bromo-2-aminopyrimidine |
|||
| TRC-B621550-10G | Toronto Research Chemicals | 10 g | Ask for price |
5-Bromo-2-aminopyrimidine |
|||
| TRC-B621550-1G | Toronto Research Chemicals | 1 g | Ask for price |
5-Bromo-2-aminopyrimidine |
|||
| TRC-B621550-5G | Toronto Research Chemicals | 5 g | Ask for price |
2-Bromo-3-amino-5-chloropyridine |
|||
| 20-abx183093 | Abbexa |
|
|
10-Bromo-1-aminodecane, Hydrobromide |
|||
| B679485 | Toronto Research Chemicals | 100mg | EUR 817 |
10-Bromo-1-aminodecane, Hydrobromide |
|||
| MBS6069575-25mg | MyBiosource | 25(mg | EUR 525 |
10-Bromo-1-aminodecane, Hydrobromide |
|||
| MBS6069575-5x25mg | MyBiosource | 5x25mg | EUR 2210 |
10-Bromo-1-aminodecane, Hydrobromide |
|||
| TRC-B679485-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
12-Bromo-1-aminododecane, Hydrobromide |
|||
| B679575 | Toronto Research Chemicals | 250mg | EUR 173 |
|
Description: 14502-45-5 |
|||
12-Bromo-1-aminododecane, Hydrobromide |
|||
| MBS6025550-25mg | MyBiosource | 25(mg | EUR 525 |
12-Bromo-1-aminododecane, Hydrobromide |
|||
| MBS6025550-5x25mg | MyBiosource | 5x25mg | EUR 2210 |
12-Bromo-1-aminododecane, Hydrobromide |
|||
| TRC-B679575-250MG | Toronto Research Chemicals | 250 mg | Ask for price |
12-Bromo-1-aminododecane, Hydrobromide |
|||
| TRC-B679575-25MG | Toronto Research Chemicals | 25 mg | Ask for price |
Bromoauric Acid |
|||
| B18610 | Pfaltz & Bauer | 1G | EUR 358.23 |
|
Description: CAS N° 307318-86-1 |
|||
Bromoacetic acid |
|||
| 558627 | MedKoo Biosciences | 250.0g | EUR 210 |
Bromoacetic Acid |
|||
| 05414-82 | NACALAI TESQUE | 25G | EUR 16.52 |
Bromoacetic acid |
|||
| GL0337 | Glentham Life Sciences | 100g | EUR 37.5 |
2-Bromoacetic Acid |
|||
| B679075 | Toronto Research Chemicals | 10g | EUR 81 |
|
Description: 79-08-3 |
|||
Bromoacetic acid - 1ML |
|||
| S-520 | Scientific Laboratory Supplies | 1ML | EUR 98.55 |
2-Bromoacetic Acid |
|||
| TRC-B679075-1G | Toronto Research Chemicals | 1 g | Ask for price |
2-Bromoacetic Acid |
|||
| TRC-B679075-50G | Toronto Research Chemicals | 50 g | Ask for price |
2-Bromoacetic Acid |
|||
| TRC-B679075-10G | Toronto Research Chemicals | 10 g | Ask for price |
Bromoacetic Acid-d3 |
|||
| B679081 | Toronto Research Chemicals | 100mg | EUR 57 |
|
Description: 14341-48-1 |
|||
Bromoacetic Acid-d2 |
|||
| B679082 | Toronto Research Chemicals | 100mg | EUR 851 |
|
Description: 41830-86-8 |
|||
Bromoacetic Acid-d3 |
|||
| TRC-B679081-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
Bromoacetic Acid-d2 |
|||
| TRC-B679082-1G | Toronto Research Chemicals | 1 g | Ask for price |
Bromoacetic Acid-d2 |
|||
| TRC-B679082-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
Bromoacetic Acid-d2 |
|||
| TRC-B679082-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
Bromoacetic Acid-d3 |
|||
| TRC-B679081-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
Bromoacetic Acid-d3 |
|||
| TRC-B679081-50MG | Toronto Research Chemicals | 50 mg | Ask for price |
Bromoacetic Acid pure, 99% |
|||
| 39903 | Sisco Laboratories | 100 Gms | EUR 6.08 |
|
Description: Part B |
|||
(E)-3-Bromoacrylic Acid |
|||
| B679400 | Toronto Research Chemicals | 100mg | EUR 52 |
|
Description: 6213-89-4 |
|||
(E)-3-Bromoacrylic Acid |
|||
| TRC-B679400-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
(E)-3-Bromoacrylic Acid |
|||
| TRC-B679400-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
(E)-3-Bromoacrylic Acid |
|||
| TRC-B679400-50MG | Toronto Research Chemicals | 50 mg | Ask for price |
5-Bromoanthranilic Acid |
|||
| B18599 | Pfaltz & Bauer | 5G | EUR 194.32 |
|
Description: CAS N° 5794-88-7 |
|||
5-Bromoanthranilic Acid |
|||
| MBS6033837-10g | MyBiosource | 10(g | EUR 505 |
5-Bromoanthranilic Acid |
|||
| MBS6033837-5x10g | MyBiosource | 5x10g | EUR 2125 |
Bromoacetic-1,2-13C2 Acid |
|||
| B679078 | Toronto Research Chemicals | 1g | EUR 1774 |
|
Description: 52947-00-9 |
|||
Bromoacetic-1,2-13C2 Acid |
|||
| TRC-B679078-250MG | Toronto Research Chemicals | 250 mg | Ask for price |
Bromoacetic-1,2-13C2 Acid |
|||
| TRC-B679078-5G | Toronto Research Chemicals | 5 g | Ask for price |
Bromoacetic-1,2-13C2 Acid |
|||
| TRC-B679078-1G | Toronto Research Chemicals | 1 g | Ask for price |
Bromoacetic-2-13C Acid |
|||
| B679076 | Toronto Research Chemicals | 50mg | EUR 123 |
|
Description: 64891-77-6 |
|||
Bromoacetic-1-13C Acid |
|||
| B679077 | Toronto Research Chemicals | 500mg | EUR 1774 |
|
Description: 57858-24-9 |
|||
Bromoacetic-1-13C Acid |
|||
| MBS6032653-500mg | MyBiosource | 500(mg | EUR 590 |
Bromoacetic-1-13C Acid |
|||
| MBS6032653-5x500mg | MyBiosource | 5x500mg | EUR 2500 |
Bromoacetic-1-13C Acid |
|||
| TRC-B679077-5G | Toronto Research Chemicals | 5 g | Ask for price |
Bromoacetic-1-13C Acid |
|||
| TRC-B679077-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
Bromoacetic-2-13C Acid |
|||
| TRC-B679076-50MG | Toronto Research Chemicals | 50 mg | Ask for price |
Bromoacetic-1,2-13C2 Acid-d2 |
|||
| B679079 | Toronto Research Chemicals | 250mg | EUR 3000 |
Bromoacetic-1,2-13C2 Acid-d2 |
|||
| TRC-B679079-250MG | Toronto Research Chemicals | 250 mg | Ask for price |
4-(2-Bromoacetyl)benzoic Acid |
|||
| B679250 | Toronto Research Chemicals | 750mg | EUR 800 |
|
Description: 20099-90-5 |
|||
4-(2-Bromoacetyl)benzoic Acid |
|||
| TRC-B679250-750MG | Toronto Research Chemicals | 750 mg | Ask for price |
4-Bromo A-23187, free acid |
|||
| 59006-1 | Biotium | EA | EUR 205 |
7-Bromoacetylaminocephalosporanic Acid |
|||
| B679125 | Toronto Research Chemicals | 100mg | EUR 1608 |
|
Description: 26973-80-8 |
|||
7-Bromoacetylaminocephalosporanic Acid |
|||
| MBS6098574-100mg | MyBiosource | 100(mg | EUR 610 |
7-Bromoacetylaminocephalosporanic Acid |
|||
| MBS6098574-5x100mg | MyBiosource | 5x100mg | EUR 2600 |
2-Bromoacetic Acid Phenylmethyl Ester |
|||
| B679115 | Toronto Research Chemicals | 100g | EUR 109 |
|
Description: 5437-45-6 |
|||
2-Bromoacetic Acid Phenylmethyl Ester |
|||
| TRC-B679115-10G | Toronto Research Chemicals | 10 g | Ask for price |
2-Bromoacetic Acid Phenylmethyl Ester |
|||
| TRC-B679115-50G | Toronto Research Chemicals | 50 g | Ask for price |
2-Bromoacetic Acid Phenylmethyl Ester |
|||
| TRC-B679115-100G | Toronto Research Chemicals | 100 g | Ask for price |
8-Bromo-AMP |
|||
| HY-134266 | MedChemExpress | 5 mg | EUR 270.57 |
|
Description: 8-Bromo-AMP (8-Bromoadenosine 5'-monophosphate) is a membrane permeable cAMP analogue. 8-Bromo-AMP can improve the ability of the heart to recover from ischemia and reperfusion by increasing the levels of ATP, ADP, and total adenine nucleotides[1][2]. |
|||
8-Bromo-AMP |
|||
| MBS5800270-5mg | MyBiosource | 5(mg | EUR 915 |
8-Bromo-AMP |
|||
| MBS5800270-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
8-Bromo-AMP |
|||
| NU-156-25 | Jena Bioscience GmbH | 25mg | EUR 101.91 |
8-Bromo-AMP |
|||
| NU-156-5 | Jena Bioscience GmbH | 5mg | EUR 48.54 |
8-Bromo-AMP |
|||
| T39890-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: 8-Bromo-AMP |
|||
8-Bromo-AMP |
|||
| T39890-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: 8-Bromo-AMP |
|||
8-Bromo-AMP |
|||
| T39890-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: 8-Bromo-AMP |
|||
8-Bromo-AMP |
|||
| T39890-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: 8-Bromo-AMP |
|||
8-Bromo-AMP |
|||
| T39890-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: 8-Bromo-AMP |
|||
3-Bromo-1-adamantane Carboxylic Acid |
|||
| B678885 | Toronto Research Chemicals | 100mg | EUR 121 |
|
Description: 21816-08-0 |
|||
3-Bromo-1-adamantane Carboxylic Acid |
|||
| TRC-B678885-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
3-Bromo-1-adamantane Carboxylic Acid |
|||
| TRC-B678885-5G | Toronto Research Chemicals | 5 g | Ask for price |
3-Bromo-1-adamantane Carboxylic Acid |
|||
| TRC-B678885-1G | Toronto Research Chemicals | 1 g | Ask for price |
2-Bromo-acetic Acid 2-Propen-1-yl Ester |
|||
| A145063 | Toronto Research Chemicals | 1g | EUR 800 |
|
Description: 40630-84-0 |
|||
2-Bromo-acetic Acid 2-Propen-1-yl Ester |
|||
| TRC-A145063-1G | Toronto Research Chemicals | 1 g | Ask for price |
Bromoamphetamine |
|||
| D446585 | Toronto Research Chemicals | 100mg | EUR 471 |
|
Description: 64638-07-9 |
|||
Bromoamphetamine |
|||
| TRC-D446585-250MG | Toronto Research Chemicals | 250 mg | Ask for price |
Bromoamphetamine |
|||
| TRC-D446585-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
Bromoamphetamine |
|||
| TRC-D446585-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
Bromoamphetamine-d6 |
|||
| D446587 | Toronto Research Chemicals | 10mg | EUR 173 |
|
Description: 1021684-64-9 |
|||
Bromoamphetamine-d6 |
|||
| TRC-D446587-10MG | Toronto Research Chemicals | 10 mg | Ask for price |
Bromoamphetamine-d6 |
|||
| TRC-D446587-1MG | Toronto Research Chemicals | 1 mg | Ask for price |
3-Bromo-alpha,4-dihydroxy-5-methoxy-benzeneacetic Acid |
|||
| B806610 | Toronto Research Chemicals | 1g | EUR 800 |
3-Bromo-alpha,4-dihydroxy-5-methoxy-benzeneacetic Acid |
|||
| TRC-B806610-1G | Toronto Research Chemicals | 1 g | Ask for price |
2-Bromo-4,5-dimethoxybenzoic Acid (6-Bromoveratric Acid) |
|||
| MBS6021314-5g | MyBiosource | 5(g | EUR 395 |
2-Bromo-4,5-dimethoxybenzoic Acid (6-Bromoveratric Acid) |
|||
| MBS6021314-5x5g | MyBiosource | 5x5g | EUR 1630 |
N,N-Dimethyl-carbamic Acid C,C'-[5-(2-Bromoacetyl)-1,3-phenylene] Ester |
|||
| D473403 | Toronto Research Chemicals | 100mg | EUR 1535 |
|
Description: 81732-49-2 |
|||
N,N-Dimethyl-carbamic Acid C,C'-[5-(2-Bromoacetyl)-1,3-phenylene] Ester |
|||
| TRC-D473403-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
N,N-Dimethyl-carbamic Acid C,C'-[5-(2-Bromoacetyl)-1,3-phenylene] Ester |
|||
| TRC-D473403-250MG | Toronto Research Chemicals | 250 mg | Ask for price |
N,N-Dimethyl-carbamic Acid C,C'-[5-(2-Bromoacetyl)-1,3-phenylene] Ester |
|||
| TRC-D473403-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
4-Bromopicolinic Acid (4-Bromo-2-pyridinecarboxylic Acid) |
|||
| MBS6082343-100mg | MyBiosource | 100(mg | EUR 485 |
4-Bromopicolinic Acid (4-Bromo-2-pyridinecarboxylic Acid) |
|||
| MBS6082343-5x100mg | MyBiosource | 5x100mg | EUR 2025 |
Bromoacetamido-PEG2-acid |
|||
| 572201 | MedKoo Biosciences | 250.0mg | EUR 560 |
Bromoacetamido-PEG3-acid |
|||
| 572202 | MedKoo Biosciences | 100.0mg | EUR 470 |
Bromoacetamido-PEG4-acid |
|||
| 572203 | MedKoo Biosciences | 100.0mg | EUR 470 |
Bromoacetamido-PEG8-acid |
|||
| 572204 | MedKoo Biosciences | 100.0mg | EUR 630 |
Bromoacetamido-PEG4-acid |
|||
| HY-141382 | MedChemExpress | 100 mg | EUR 129.87 |
|
Description: Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Bromoacetamido-PEG4-acid is also a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2]. |
|||
Bromoacetamido-PEG8-acid |
|||
| HY-141383 | MedChemExpress | Get quote | Ask for price |
|
Description: Bromoacetamido-PEG8-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
|||
Bromoacetamido-PEG4-acid |
|||
| T14823-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bromoacetamido-PEG4-acid |
|||
Bromoacetamido-PEG4-acid |
|||
| T14823-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bromoacetamido-PEG4-acid |
|||
Bromoacetamido-PEG4-acid |
|||
| T14823-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bromoacetamido-PEG4-acid |
|||
Bromoacetamido-PEG4-acid |
|||
| T14823-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bromoacetamido-PEG4-acid |
|||
Bromoacetamido-PEG4-acid |
|||
| T14823-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bromoacetamido-PEG4-acid |
|||
Bromoacetamido-PEG8-acid |
|||
| T14827-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bromoacetamido-PEG8-acid |
|||
Bromoacetamido-PEG8-acid |
|||
| T14827-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bromoacetamido-PEG8-acid |
|||
Bromoacetamido-PEG8-acid |
|||
| T14827-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bromoacetamido-PEG8-acid |
|||
Bromoacetamido-PEG8-acid |
|||
| T14827-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bromoacetamido-PEG8-acid |
|||
Bromoacetamido-PEG8-acid |
|||
| T14827-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bromoacetamido-PEG8-acid |
|||
Bromopyruvic Acid |
|||
| B686930 | Toronto Research Chemicals | 1g | EUR 81 |
|
Description: 1113-59-3 |
|||
Bromopyruvic Acid |
|||
| MBS6089049-25g | MyBiosource | 25(g | EUR 610 |
Bromopyruvic Acid |
|||
| MBS6089049-5x25g | MyBiosource | 5x25g | EUR 2600 |
Bromopyruvic Acid |
|||
| TRC-B686930-25G | Toronto Research Chemicals | 25 g | Ask for price |
Bromopyruvic Acid |
|||
| TRC-B686930-5G | Toronto Research Chemicals | 5 g | Ask for price |
Bromopyruvic Acid |
|||
| TRC-B686930-1G | Toronto Research Chemicals | 1 g | Ask for price |
Bromosuccinic Acid |
|||
| B687800 | Toronto Research Chemicals | 100g | EUR 138 |
|
Description: 923-06-8 |
|||
Bromosuccinic Acid |
|||
| TRC-B687800-5G | Toronto Research Chemicals | 5 g | Ask for price |
Bromosuccinic Acid |
|||
| TRC-B687800-25G | Toronto Research Chemicals | 25 g | Ask for price |
Bromosuccinic Acid |
|||
| TRC-B687800-100G | Toronto Research Chemicals | 100 g | Ask for price |
Bromopyruvic Acid-13C3 |
|||
| B686932 | Toronto Research Chemicals | 25mg | EUR 1200 |
Bromopyruvic Acid-13C3 |
|||
| TRC-B686932-25MG | Toronto Research Chemicals | 25 mg | Ask for price |
Bromoiodoacetic Acid |
|||
| B684625 | Toronto Research Chemicals | 10mg | EUR 695 |
|
Description: 71815-43-5 |
|||
Bromoiodoacetic acid |
|||
| HY-133657 | MedChemExpress | Get quote | Ask for price |
|
Description: Bromoiodoacetic acid, one of iodinated haloacids, is a disinfection byproduct (DBP) at in finished drinking waters[1]. |
|||
Bromoiodoacetic acid |
|||
| MBS5800993-5mg | MyBiosource | 5(mg | EUR 915 |
Bromoiodoacetic acid |
|||
| MBS5800993-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Bromoiodoacetic acid |
|||
| T40827-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bromoiodoacetic acid |
|||
Bromoiodoacetic acid |
|||
| T40827-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bromoiodoacetic acid |
|||
Bromoiodoacetic acid |
|||
| T40827-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bromoiodoacetic acid |
|||
Bromoiodoacetic acid |
|||
| T40827-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bromoiodoacetic acid |
|||
Bromoiodoacetic acid |
|||
| T40827-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bromoiodoacetic acid |
|||
Bromoiodoacetic Acid |
|||
| TRC-B684625-10MG | Toronto Research Chemicals | 10 mg | Ask for price |
Bromoiodoacetic Acid |
|||
| TRC-B684625-1MG | Toronto Research Chemicals | 1 mg | Ask for price |
Bromoiodoacetic Acid |
|||
| TRC-B684625-5MG | Toronto Research Chemicals | 5 mg | Ask for price |
Bromochloroacetic Acid |
|||
| B680535 | Toronto Research Chemicals | 100mg | EUR 75 |
|
Description: 5589-96-8 |
|||
Bromochloroacetic Acid |
|||
| TRC-B680535-50MG | Toronto Research Chemicals | 50 mg | Ask for price |
Bromochloroacetic Acid |
|||
| TRC-B680535-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
Bromoacetamide-PEG3-C1-acid |
|||
| HY-133506 | MedChemExpress | Get quote | Ask for price |
|
Description: Bromoacetamide-PEG3-C1-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
|||
Bromoacetamido-PEG2-C2-acid |
|||
| HY-141380 | MedChemExpress | 100 mg | EUR 140.69 |
|
Description: Bromoacetamido-PEG2-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
|||
Bromoacetamido-PEG3-C2-acid |
|||
| HY-141381 | MedChemExpress | Get quote | Ask for price |
|
Description: Bromoacetamido-PEG3-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
|||
Bromoacetamide-PEG3-C1-acid |
|||
| MBS5799704-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Bromoacetamido-PEG2-C2-acid |
|||
| T14817-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bromoacetamido-PEG2-C2-acid |
|||
Bromoacetamido-PEG2-C2-acid |
|||
| T14817-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bromoacetamido-PEG2-C2-acid |
|||
Bromoacetamido-PEG2-C2-acid |
|||
| T14817-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bromoacetamido-PEG2-C2-acid |
|||
Bromoacetamido-PEG2-C2-acid |
|||
| T14817-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bromoacetamido-PEG2-C2-acid |
|||
Bromoacetamido-PEG2-C2-acid |
|||
| T14817-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bromoacetamido-PEG2-C2-acid |
|||
Bromoacetamido-PEG3-C2-acid |
|||
| T14820-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bromoacetamido-PEG3-C2-acid |
|||
Bromoacetamido-PEG3-C2-acid |
|||
| T14820-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bromoacetamido-PEG3-C2-acid |
|||
Bromoacetamido-PEG3-C2-acid |
|||
| T14820-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bromoacetamido-PEG3-C2-acid |
|||
Bromoacetamido-PEG3-C2-acid |
|||
| T14820-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bromoacetamido-PEG3-C2-acid |
|||
Bromoacetamido-PEG3-C2-acid |
|||
| T14820-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bromoacetamido-PEG3-C2-acid |
|||
Bromoacetamide-PEG3-C1-acid |
|||
| T39177-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bromoacetamide-PEG3-C1-acid |
|||
Bromoacetamide-PEG3-C1-acid |
|||
| T39177-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bromoacetamide-PEG3-C1-acid |
|||
Bromoacetamide-PEG3-C1-acid |
|||
| T39177-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bromoacetamide-PEG3-C1-acid |
|||
Bromoacetamide-PEG3-C1-acid |
|||
| T39177-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bromoacetamide-PEG3-C1-acid |
|||
Bromoacetamide-PEG3-C1-acid |
|||
| T39177-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bromoacetamide-PEG3-C1-acid |
|||
